tcsc3028 5-BrdU

5-BrdU is a nucleoside analog, and competes with thymidine for incorporation into DNA, and is used in the detection of proliferating cells.

In Vitro: Bromodeoxyuridine induces a progressive, dose-responsive suppression of cancer cell line and cancer stem cell population expansion RG2 rat glioma cells. In H9 cells and BJ fibroblasts, bromodeoxyuridine alters the cell cycle profile^[1]. BrdU is stably integrated into the DNA, and thus can be used in assessment of cell proliferation and other cell procession^[2]. 

In Vivo: Bromodeoxyuridine (300 mg/kg, i.p. or 0.8 mg/mL, p.o.) significantly slows tumor progression in rat glioma RG2 tumor model^[1].